Showing results (101-110 of 171) with videos related to
Sort By:
Pageof 18
Thrombosis Research|February 14, 2009
Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administrationSofie S Hedegaard, Anne-Mette Hvas, Erik L Grove, et al.Journal of the American College of Cardiology|January 18, 2006
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitusFrancesca Santilli, Giovanni Davì, Agostino Consoli, et al.European Journal of Immunology|May 1, 2002
Distinct expression of cyclooxygenase-1 and -2 in the human thymusBianca Rocca, Nicola Maggiano, Aida Habib, et al.Neuromuscular Disorders : NMD|July 13, 2005
Impaired primary hemostasis with normal platelet function in Duchenne muscular dystrophy during highly-invasive spinal surgeryFrancesco Turturro, Bianca Rocca, Stefano Gumina, et al.Circulation|March 24, 2004
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjectsMarta L Capone, Stefania Tacconelli, Maria G Sciulli, et al.Science (New York, N.Y.)|April 20, 2002
Role of prostacyclin in the cardiovascular response to thromboxane A2Yan Cheng, Sandra C Austin, Bianca Rocca, et al.Biochemical Pharmacology|February 17, 2019
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studiesBenedetta Porro, Alessandro Di Minno, Bianca Rocca, et al.Journal of Applied Physiology (Bethesda, Md. : 1985)|August 4, 2007
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodentsMarco Testa, Bianca Rocca, Lucia Spath, et al.American Journal of Hematology|June 15, 2024
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trialBianca Rocca, Alberto Tosetto, Giovanna Petrucci, et al.Free Radical Biology & Medicine|December 9, 2009
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13: A new prothrombotic mechanism in diseases associated with oxidative stressStefano Lancellotti, Vincenzo De Filippis, Nicola Pozzi, et al.Pageof 18